Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. (TSHA) has reported earnings 22 times since Mar 03, 2021. The stock moves an average of ±15.88% the day after reporting, closing higher 59.1% of the time. Its largest post-earnings gain was +188.23% (Aug 14, 2023) and its largest decline was -19.06% (Aug 11, 2022). The next earnings report is predicted for 2026-08-12 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±15.88%
Positive %
59.1%
Negative %
40.9%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 06, 2026 | ☀ PRE | $6.70 | $7.30 | $6.99 | 265,931 | +0.58% | open_in_new |
| Mar 19, 2026 | ☀ PRE | $4.55 | $4.66 | $4.56 | 5,664,000 | +2.47% | open_in_new |
| Nov 04, 2025 | ☀ PRE | $4.29 | $4.54 | $4.27 | 3,759,600 | -4.26% | open_in_new |
| Aug 12, 2025 | ☀ PRE | $2.78 | $3.00 | $2.91 | 4,903,300 | +5.43% | open_in_new |
| May 15, 2025 | ☀ PRE | $2.51 | $2.77 | $2.56 | 6,645,700 | +8.02% | open_in_new |
| Feb 26, 2025 | ☀ PRE | $1.80 | $1.89 | $1.62 | 2,118,500 | -4.71% | open_in_new |
| Nov 13, 2024 | ☽ POST | $2.47 | $2.53 | $2.21 | 6,876,400 | +2.71% | open_in_new |
| Aug 12, 2024 | ☀ PRE | $2.14 | $2.22 | $2.04 | 1,836,700 | -2.39% | open_in_new |
| Jun 26, 2024 | ☀ PRE | $2.24 | $2.26 | $2.04 | 10,169,900 | -17.24% | open_in_new |
| Mar 19, 2024 | ☽ POST | $2.10 | $2.33 | $2.25 | 4,032,500 | +31.56% | open_in_new |
| Nov 14, 2023 | ☽ POST | $1.27 | $1.56 | $1.33 | 3,729,900 | +26.32% | open_in_new |
| Aug 14, 2023 | ☀ PRE | $1.52 | $2.21 | $2.13 | 158,886,800 | +188.23% | open_in_new |
| May 15, 2023 | ☽ POST | $0.70 | $0.70 | $0.69 | 365,400 | -0.14% | open_in_new |
| Mar 28, 2023 | ☽ POST | $0.68 | $0.70 | $0.65 | 444,800 | -0.31% | open_in_new |
| Nov 08, 2022 | ☀ PRE | $2.02 | $2.23 | $2.20 | 3,126,600 | +10% | open_in_new |
| Aug 11, 2022 | ☀ PRE | $4.88 | $4.88 | $3.95 | 353,800 | -19.06% | open_in_new |
| May 16, 2022 | ☀ PRE | $3.38 | $3.72 | $3.32 | 388,300 | -3.49% | open_in_new |
| Mar 31, 2022 | ☀ PRE | $6.15 | $7.08 | $6.52 | 319,900 | +6.02% | open_in_new |
| Nov 10, 2021 | ☀ PRE | $15.17 | $16.08 | $15.74 | 279,300 | +5.14% | open_in_new |
| Aug 16, 2021 | ☀ PRE | $17.66 | $17.66 | $15.82 | 102,600 | -8.98% | open_in_new |
| May 11, 2021 | ☀ PRE | $20.08 | $21.85 | $21.00 | 85,100 | +2.34% | open_in_new |
| Mar 03, 2021 | ☀ PRE | $25.50 | $26.46 | $25.21 | 77,300 | +0% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±15.88%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260506 | open_in_new SEC.gov |
| 8-K | 20260506 | open_in_new SEC.gov |
| ARS | 20260422 | open_in_new SEC.gov |
Frequently asked about TSHA earnings
When does Taysha Gene Therapies, Inc. report earnings next? expand_more
Taysha Gene Therapies, Inc. (TSHA)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does TSHA stock move after earnings? expand_more
Over 22 reports, TSHA has moved an average of ±15.88% the session after earnings, closing higher 59.1% of the time.
What was TSHA's biggest post-earnings move? expand_more
TSHA's largest post-earnings gain on record was +188.23% on Aug 14, 2023, and its largest decline was -19.06% on Aug 11, 2022.
Where can I find Taysha Gene Therapies, Inc.'s SEC filings? expand_more
All of Taysha Gene Therapies, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right